Suchergebnisse

"The Pharmaceutical Industry: Is Pharmaceutical Research Safe and Unbiased?; Are Prescription Drugs Appropriately Regulated?; Are Pharmaceutical Marketing Practices Ethical?; Is the Cost of Prescription Drugs in America Appropriate?"--Provided by publisher

On November 4th, 2013, global health care giant Johnson & Johnson and its subsidiaries reached a settlement amount of $2.2 billion dollars. Johnson & Johnson settled to pay this amount to resolve the civil and criminal allegations of promotions not approved as safe and effective, kickbacks to physicians, and violations based on the False claim act. This type of offense has been common with pharmaceutical companies for the past ten years, but the federal government still gives pharmaceutical companies tax breaks which represent billions of dollars in lost revenue for the federal government. With this type of exemption, pharmaceutical companies are given an incentive to commit fraud for corporate greed while neglecting to put funds towards research and development.

S. 22-24: Pharmaceutical companies in the A.B.P.I.

Physician-pharmaceutical industry interactions continue to generate heated debate in academic and public domains, both in the United States and abroad. Despite this, recent research suggests that physicians and physicians-in-training remain uninformed of the core issues and are ill-prepared to understand pharmaceutical industry promotion. Furthermore, few medical curricula address this issue, despite warnings of the imperative need to address this gap in the education of tomorrow's physicians. There is a vast medical literature on this topic, but no single, concise resource. This book aims to fill that gap by providing a resource that explains the essential elements of this subject. The text makes the reader more aware of the key ethical issues and allows the reader to be a more savvy interpreter of industry promotion, have a heightened awareness of the public and medical legal consequences of some physician-pharmaceutical industry interactions, and be better equipped to handle real-life encounters with industry